LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...

As COVID-19 cases continue to rise across the United States, scientists are monitoring the spread of a new variant called LB.1. The highly contagious omicron subvariant, along with the fast-growing ...

Many drugs are available for schizophrenia, but insufficient efficacy and intolerable side effects leave an unmet need that biotech companies are still trying to fill. LB Pharmaceuticals is not ...

A summertime wave of COVID-19 infections is arriving earlier than last year across a growing share of the country, federal data suggests, as a new variant called LB.1 could be on track to become the ...

LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new chief commercial officers, according to a pair of announcements this week. New ...

There are no signs so far that the new LB.1 variant is causing more severe disease in COVID-19 patients, the Centers for Disease Control and Prevention says, as infections have begun to accelerate in ...

Despite the stagnant biotech IPO market of the last six months, LB Pharmaceuticals has set out plans to reel in hundreds of millions of dollars through its upcoming public debut. The ...

LB Pharmaceuticals (LBRX), a drug developer focused on neuropsychiatric diseases has announced terms for its initial public offering on Nasdaq seeking a valuation of more than $300M according to a ...

Byers played for the team from 1983 to 1992 and went to the Stanley Cup finals twice before becoming a Boston radio personality Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Robert Buchel was preparing for weight loss surgery to minimize his 842-lb. frame on My 600-Lb. Life when he died of a heart attack Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering ...